The recommendation of early clinical intervention of aspirin and high dose vitamin C for 2019 novel coronavirus pneumonia

Update:Mar. 14, 2020Total Views:10502Total Downloads:1068 DownloadMobile

Author: Fu-Xiang ZHOU * Yun FU Guo-Hui XIAO

Affiliation: Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan 430071, China

Keywords: Novel coronavirus pneumonia cGAS-STING pathway Oxidative stress Aspirin High dose vitamin C

DOI:10.12173/j.issn.1004-5511.2020.03.03

Reference:Zhou FX, Fu Y, Xiao GH. The recommendation of early clinical intervention of aspirin and high dose vitamin C for 2019 novel coronavirus pneumonia[J]. Yixue Xinzhi Zazhi, 2020, 30(3): 206-208. DOI: 10.12173/j.issn.1004-5511.2020.03.03.[Article in Chinese]

  • Abstract
  • Full-text
  • Figures and Tables
  • References
Abstract

Viral infection activates the cGAS-STING signaling pathway and induces an antiviral response with in-creased expression of a series of cytokines including interferon. If the antiviral effect fails to effectively inhibit virus replication and eliminate the virus, normal alveolar tissue will be destroyed by the virus and serious inflammatory reaction. The primary autopsy confirmed the destruction of bronchoalveolar epithe-lial cells and interstitial tissues and server inflammatory injury. In the absence of effective antiviral drugs, it is important that the antiviral immunity and anti-oxidant stress are the main measures to prevent the progress of the disease. Aspirin plays an important role in blocking the pathway of cGAS-STING-cytokines. High dose vitamin C can alleviate the oxidative injury and promote tissue repair, therefor to reduce the mortality of 2019 novel coronavirus pneumonia and shorten the days staying in ICU. Early clinical interven-tion of aspirin and high dose vitamin C is recommended.

Full-text
  Please download the PDF version to read the full text: download
References

1.中华人民共和国国家卫生健康委员会. 疫情通报: 截至2月24日24时新型冠状病毒肺炎疫情最新情况[EB/OL]. (2020-02-25) [Access on 2020-03-10]. http://www.nhc.gov.cn/xcs/yqtb/202002/67e6c59a84bd4f07b6ca4a4c5ffabb79.shtml.

2.Xu Z, Shi L, Wang YJ, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome[J]. Lancet Respir Med, [published online ahead of print February 18, 2020]. DOI: 10.1016/S2213-2600(20)30076-X.

3.Wang C, Guan Y, Lv M, et al. Manganese increases the sensitivity of the cGAS-STING pathway for double-stranded DNA and is required for the host defense against DNA viruses[J]. Immunity, 2018, 48(4): 675-687. DOI: 10.1016/j.immuni.2018.03.017.

4.Goto A, Okado K, Martins N, et al. The kinase IKKβ regulates a STING- and NF-κB-dependent antiviral response pathway in drosophila[J]. Immunity, 2018, 49(2): 225-234. DOI: 10.1016/j.immuni.2018.07.013.

5.Wang YT, Ning XH, Gao PF, et al. Inflammasome activation triggers caspase-1-mediated cleavage of cGAS to regulate responses to DNA virus infection[J]. Immunity, 2017, 46(3): 393-404. DOI: 10.1016/j.immuni.2017.02.011.

6.Dai J, Huang YJ, He X, et al. Acetylation blocks cGAS activity and inhibits self-DNA-induced au-toimmunity[J]. Cell, 2019, 176(6): 1447-1460. DOI: 10.1016/j.cell.2019.01.016.

7.中华人民共和国国家卫生健康委员会, 国家中医药管理局. 关于印发新型冠状病毒肺炎诊疗方案(试行第六版)的通知[EB/OL]. (2020-02-18) [Access on 2020-03-10]. http://www.gov.cn/zhengce/zhengceku/2020-02/19/content_5480948.htm.

8.Holshue ML, DeBolt C, Lindquist S, et al. First case of 2019 novel coronavirus in the United States[J]. N Engl J Med, 2020, 382(10): 929-936. DOI: 10.1056/NEJMoa2001191.

9.长沙晚报. 北大一院王广发:一种抗艾滋病病毒的药对我很有效[EB/OL]. (2020-01-24) [Access on 2020-02-06]. https://new.qq.com/omn/20200124/20200124A04FVA00.

10.Fowler AA, Truwit JD, Hite RD, et al. Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: The CITRIS-ALI randomized clinical trial[J]. JAMA, 2019, 322(13): 1261-1270. DOI: 10.1001/jama.2019.11825.

11.陈建斌, 饶邦复, 朱治本, 等. 静脉注射大剂量维生素C的药代动力学研究[J]. 中国药学杂志, 1995, 20(3): 678-679. [Chen JB, Rao BF, Zhu ZB, et al. Study on pharmacokinetics of intravenous high-dose vitamin C[J]. Chinese Pharmaceutical Journal, 1995, 20(3): 678-679.]

Hot Papers